Related Experiment Video
Updated: Jan 25, 2026

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
Published on: March 28, 2018
Beyond an Obvious Cause of Cholestasis in a Toddler: Compound Heterozygosity for ABCB11 Mutations
Maria Fotoulaki1, Styliani Giza2, Milan Jirsa3
1Fourth Department of Pediatrics and mfotoul@otenet.gr.
Insights
This case highlights a rare genetic liver disorder in a child initially misdiagnosed. Molecular analysis revealed compound heterozygous mutations in ABCB11, leading to progressive familial intrahepatic cholestasis type 2.
Area of Science:
- Hepatology
- Medical Genetics
- Pediatric Gastroenterology
Background:
- Jaundice in children can be challenging to diagnose, with drug-induced liver injury being a common initial consideration.
- Inherited cholestatic disorders may present with severe conjugated hyperbilirubinemia, mimicking other liver conditions.
Observation:
- A 27-month-old girl presented with severe conjugated hyperbilirubinemia after cefprozil and homeopathic cantharidin treatment.
- Liver biopsy showed cholestasis and fibrosis, with absent canalicular gamma-glutamyl transpeptidase but preserved bile salt export pump expression.
- Genetic analysis identified compound heterozygous mutations in ABCB11, indicating a complex inherited cholestatic disorder.
Findings:
- The patient harbored a missense mutation (p.Arg1050Cys) linked to benign recurrent intrahepatic cholestasis type 2 and a nonsense mutation (p.Glu1302Ter) linked to progressive familial intrahepatic cholestasis type 2.
- Despite ursodeoxycholic acid treatment, the patient progressed to cirrhosis within 5 years, necessitating a liver transplant.
- This case underscores the importance of genetic testing for unexplained cholestasis.
Implications:
- Accurate diagnosis of inherited cholestatic disorders is crucial for appropriate management and prognosis.
- Molecular genetic analysis of ABCB11 is essential for identifying patients with progressive familial intrahepatic cholestasis type 2 and benign recurrent intrahepatic cholestasis type 2.
- Early identification of genetic causes can guide clinical decisions and potentially improve outcomes for children with cholestatic liver disease.
Abstract:
A 27-month-old girl presented with a short history of jaundice initially attributed to drug-induced liver injury. During the preceding 20 days, she had received a 10-day course of cefprozil and 2 doses of a homeopathic preparation of cantharidin for cystitis. Severe conjugated hyperbilirubinemia was present with normal γ-glutamyl transpeptidase activity. Liver biopsy revealed marked canalicular and hepatocellular cholestasis, with moderate hepatocellular disarray, as well as evidence of chronicity, including moderate portal-tract and perisinusoidal fibrosis. Immunohistochemical studies revealed that bile salt export pump expression was preserved, whereas canalicular γ-glutamyl transpeptidase expression was largely absent. An inherited cholestatic disorder was suspected. The entire coding region of ABCB11, encoding bile salt export pump, was analyzed. The patient was found to be a compound heterozygote for the missense mutation c.3148C>T (p.Arg1050Cys) associated with benign recurrent intrahepatic cholestasis type 2 in the homozygous state and for the nonsense mutation c.3904G>T (p.Glu1302Ter) associated with progressive familial intrahepatic cholestasis type 2. Despite initial improvement with ursodeoxycholic acid, over the course of 5 years the patient developed cirrhosis that required liver transplant. Our report emphasizes the need for molecular studies even in patients with putatively "explained" cholestasis to reveal the entire spectrum of inherited cholestatic disorders.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Mutation, Gene Flow, and Genetic Drift
Molecules and Compounds
Organic Compounds

